Literature DB >> 6321468

Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product.

T H Lee, J M Menica-Huerta, C Shih, E J Corey, R A Lewis, K F Austen.   

Abstract

Leukotriene B5 (LTB5) and three stereoisomers were prepared biosynthetically from eicosapentaenoic acid and compared with the analogous derivatives of arachidonic acid for their chemotactic and aggregating effects on human neutrophilic polymorphonuclear leukocytes. Leukotriene B4 (LTB4), LTB5, and the 6-trans-diastereoisomers of each were generated by activating polymorphonuclear leukocytes with the calcium ionophore A23187 in the presence of 14C-labeled and unlabeled arachidonic acid or 14C-labeled and unlabeled eicosapentaenoic acid, respectively. The double lipoxygenase products, (5S,12S)-6-trans-8-cis-LTB4 and (5S,12S)-6-trans-8-cis-LTB5, were generated from 5S-hydroxyeicosatetraenoic acid and racemic 5-hydroxyeicosapentaenoic acid intermediates by incubation with platelet sonicates. The products of each reaction were isolated by reverse-phase-high performance liquid chromatography and identified by their retention times relative to the appropriate totally synthetic standards, ultraviolet absorption spectra, immunoreactivity in a radioimmunoassay for LTB4, and, for all but the double lipoxygenase products, by incorporation of radiolabel from the specific polyunsaturated fatty acid source. When the concentration of LTB5 eliciting maximum chemotactic response of human polymorphonuclear leukocytes, 50 ng/ml (1.5 X 10(-7) M), and that eliciting a maximum aggregation response, 20 ng/ml (5.9 X 10(-8) M), were compared with the interpolated values of LTB4 eliciting comparable effects, the potency of LTB5 relative to LTB4 was approximately 1:8 as a chemotactic agent and about 1:20 as an aggregating agent. The double lipoxygenase products and the resolved 6-trans-diastereoisomers of the pentaene and tetraene series were about 2 logs less active as chemotactic factors than LTB4 and only (5S,12S)-6-trans-8-cis-LTB4 had even minimal aggregating activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321468

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial.

Authors:  A B Hawthorne; T K Daneshmend; C J Hawkey; A Belluzzi; S J Everitt; G K Holmes; C Malkinson; M Z Shaheen; J E Willars
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

Review 2.  Fish oil in critical illness: mechanisms and clinical applications.

Authors:  Renee D Stapleton; Julie M Martin; Konstantin Mayer
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

3.  Modulation of the contractile activity of the guinea-pig lung parenchymal strip by exogenous 5,8,11,14,17-eicosapentaenoic acid.

Authors:  T Simmet; J Aissa; D Sutter; H Juan; B A Peskar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-06       Impact factor: 3.000

4.  New findings in the fatty acid composition of individual platelet phospholipids in man after dietary fish oil supplementation.

Authors:  T A Mori; J P Codde; R Vandongen; L J Beilin
Journal:  Lipids       Date:  1987-10       Impact factor: 1.880

5.  Effect of dietary supplementation with fish oil lipids on mild asthma.

Authors:  J P Arm; C E Horton; J M Mencia-Huerta; F House; N M Eiser; T J Clark; B W Spur; T H Lee
Journal:  Thorax       Date:  1988-02       Impact factor: 9.139

Review 6.  Role of arachidonic acid metabolites and reactive oxygen species in glomerular immune-inflammatory process.

Authors:  R Ardaillou; L Baud; J Sraer
Journal:  Springer Semin Immunopathol       Date:  1987

7.  Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid.

Authors:  D G Payan; M Y Wong; T Chernov-Rogan; F H Valone; W C Pickett; V A Blake; W M Gold; E J Goetzl
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

Review 8.  Effects of modulation of inflammatory and immune parameters in patients with rheumatic and inflammatory disease receiving dietary supplementation of n-3 and n-6 fatty acids.

Authors:  J M Kremer
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

9.  Formation of 8,15-dihydroxy eicosatetraenoic acidvia 15- and 12-lipoxygenases in fish gill.

Authors:  J B German; R Berger
Journal:  Lipids       Date:  1990-12       Impact factor: 1.880

10.  The effect of dietary linoleic acid on the fatty acid composition of individual phospholipid and lipoxygenase products from gills and leucocytes of Atlantic salmon (Salmo salar).

Authors:  J Gordon Bell; R S Raynard; J R Sargent
Journal:  Lipids       Date:  1991-06       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.